(ARDX) Ardelyx - Performance -24.4% in 12m
ARDX performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-28.93%
#46 in Peer-Group
Rel. Strength
21.64%
#6023 in Stock-Universe
Total Return 12m
-24.37%
#84 in Peer-Group
Total Return 5y
-33.92%
#48 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | - |
| High / Low | USD |
|---|---|
| 52 Week High | 6.93 USD |
| 52 Week Low | 3.28 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 90.46 |
| Buy/Sell Signal +-5 | 1.10 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: ARDX (-24.4%) vs XBI (-11.6%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
-1.6% | 59% | 71.9% | 24.1 | 14.3 | 0.24 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
1.62% | -10.4% | 150% | 12 | 11 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
-1.03% | -8.54% | 32.3% | 27.4 | 14.2 | 0.99 | 0.60% | 41% |
| NBIX NASDAQ Neurocrine Biosciences |
4.99% | -11% | 0.55% | 45.7 | 26.2 | 0.27 | 18.7% | -34.3% |
| BIM PA Biomerieux |
-0.99% | 26.5% | -5.28% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| KMDA NASDAQ Kamada |
5.73% | 34.5% | -14.4% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-7.94% | 44.1% | -14.3% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
-1.76% | 27.6% | 14.6% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: ARDX vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ARDX
| Total Return (including Dividends) | ARDX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 22.95% | 5.89% | 3.54% |
| 3 Months | -3.02% | 15.34% | 16.07% |
| 12 Months | -24.37% | -11.61% | 12.18% |
| 5 Years | -33.92% | -23.80% | 107.69% |
| Trend Score (consistency of price movement) | ARDX | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 95% | 65.7% | 91.4% |
| 3 Months | -28.1% | 79.4% | 97.5% |
| 12 Months | -81% | -87.3% | 46.7% |
| 5 Years | 10% | -51.8% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th86.00 | 19.31% | 18.75% |
| 3 Month | %th25.00 | -13.60% | -16.44% |
| 12 Month | %th58.50 | -12.08% | -32.58% |
| 5 Years | %th76.50 | -9.03% | -68.18% |
FAQs
Does Ardelyx (ARDX) outperform the market?
No,
over the last 12 months ARDX made -24.37%, while its related Sector, the SPDR S&P Biotech (XBI) made -11.61%.
Over the last 3 months ARDX made -3.02%, while XBI made 15.34%.
Performance Comparison ARDX vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
ARDX vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 0.2% | 19.4% | -21.5% | -37% |
| US NASDAQ 100 | QQQ | -0.3% | 18.6% | -23.9% | -37% |
| German DAX 40 | DAX | 0.1% | 21% | -34.5% | -54% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -0.4% | 18% | -25.5% | -44% |
| Hongkong Hang Seng | HSI | -0.5% | 20.5% | -43.5% | -59% |
| India NIFTY 50 | INDA | 1.9% | 22.4% | -22.9% | -21% |
| Brasil Bovespa | EWZ | 4.8% | 25.9% | -33.6% | -25% |
ARDX vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 0.4% | 20.1% | -28.6% | -49% |
| Consumer Discretionary | XLY | -1.3% | 18.9% | -16.7% | -42% |
| Consumer Staples | XLP | 2% | 22.7% | -22.9% | -32% |
| Energy | XLE | -1.8% | 21.8% | -14.1% | -23% |
| Financial | XLF | 0.7% | 18.6% | -25.6% | -48% |
| Health Care | XLV | -0% | 23% | -13.2% | -17% |
| Industrial | XLI | -1% | 17.5% | -28.9% | -47% |
| Materials | XLB | -0.1% | 19.1% | -22.5% | -27% |
| Real Estate | XLRE | -0.4% | 22.2% | -22.1% | -32% |
| Technology | XLK | 0.2% | 17.6% | -28.5% | -34% |
| Utilities | XLU | -0.5% | 20.1% | -26.8% | -47% |
| Aerospace & Defense | XAR | -2.6% | 13.1% | -44.4% | -74% |
| Biotech | XBI | -5.2% | 17.1% | -17.8% | -13% |
| Homebuilder | XHB | -2.4% | 13.7% | -13.6% | -21% |
| Retail | XRT | -0.6% | 17.8% | -20.6% | -32% |
ARDX vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 2.7% | 27.2% | -5.12% | -18% |
| Natural Gas | UNG | -4.3% | 31.4% | 2.8% | -32% |
| Gold | GLD | -0.4% | 24.6% | -39.1% | -61% |
| Silver | SLV | -2.5% | 19.2% | -38.4% | -47% |
| Copper | CPER | -1.2% | 9.3% | -40.2% | -47% |
ARDX vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 1.6% | 23.1% | -16% | -20% |
| iShares High Yield Corp. Bond | HYG | 0.6% | 22.1% | -19.5% | -33% |